Factset Research Systems Inc: Form 10-Q for the period ended Feb 28, 2019
Filed with the SEC on Apr 9, 2019 and accepted by EDGAR at Apr 9, 2019, 16:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-02-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2018-12-01 to 2019-02-28 | $165.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2018-09-01 to 2019-02-28 | $331.9m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2018-12-01 to 2019-02-28 | $81.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2018-09-01 to 2019-02-28 | $165.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-12-01 to 2019-02-28 | $108.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-09-01 to 2019-02-28 | $209.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2018-12-01 to 2019-02-28 | $19.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-09-01 to 2019-02-28 | $31.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-12-01 to 2019-02-28 | $84.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-09-01 to 2019-02-28 | $169.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-12-01 to 2019-02-28 | $2.19 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2018-09-01 to 2019-02-28 | $4.37 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-12-01 to 2019-02-28 | $2.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2018-09-01 to 2019-02-28 | $4.44 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-12-01 to 2019-02-28 | 38,619,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2018-09-01 to 2019-02-28 | 38,714,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2018-09-01 to 2019-02-28 | $145.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2018-12-01 to 2019-02-28 | $12.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2018-09-01 to 2019-02-28 | $21.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2018-09-01 to 2019-02-28 | $48.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2018-09-01 to 2019-02-28 | $110.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-02-28 | $218.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-02-28 | $488.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-02-28 | $1.46bn | us-gaap:Assets |
| Current liabilities | At period end2019-02-28 | $198.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-02-28 | $865.5m | us-gaap:Liabilities |
| Long-term debt | At period end2019-02-28 | $574.8m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2019-02-28 | $599.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-19-006813. Last ingested by Listed: Nov 11, 2026, 01:02 ET. Listed shows no prices and gives no investment advice.